BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10342744)

  • 1. Accessory and adhesion molecules expressed on murine epidermal Langerhans cells and the modulation by cytokines.
    Nakamura K; Tamaki K
    J Dermatol Sci; 1998 May; 20(1):14-20. PubMed ID: 10342744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective regulation of ICAM-1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells.
    Chang CH; Furue M; Tamaki K
    Eur J Immunol; 1994 Nov; 24(11):2889-95. PubMed ID: 7957579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adhesion and migration of epidermal dendritic cells].
    Staquet MJ
    Pathol Biol (Paris); 1995 Dec; 43(10):858-62. PubMed ID: 8786890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization.
    Kimber I; Cumberbatch M; Dearman RJ; Bhushan M; Griffiths CE
    Br J Dermatol; 2000 Mar; 142(3):401-12. PubMed ID: 10735943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-presenting cells in essential fatty acid-deficient murine epidermis: keratinocytes bearing class II (Ia) antigens may potentiate the accessory cell function of Langerhans cells.
    Udey MC; Peck RD; Pentland AP; Schreiner GF; Lefkowith JB
    J Invest Dermatol; 1991 Jun; 96(6):950-8. PubMed ID: 1828477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multistep navigation of Langerhans/dendritic cells in and out of the skin.
    Jakob T; Ring J; Udey MC
    J Allergy Clin Immunol; 2001 Nov; 108(5):688-96. PubMed ID: 11692090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ.
    Schwarzenberger K; Udey MC
    J Invest Dermatol; 1996 Mar; 106(3):553-8. PubMed ID: 8648193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression.
    Ozawa H; Aiba S; Nakagawa ; Tagami H
    Eur J Immunol; 1996 Mar; 26(3):648-52. PubMed ID: 8605933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration of murine epidermal Langerhans cells to regional lymph nodes: engagement of major histocompatibility complex class II antigens induces migration of Langerhans cells.
    Yamashita K; Yano A
    Microbiol Immunol; 1994; 38(7):567-74. PubMed ID: 7968691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 6 integrins are required for Langerhans cell migration from the epidermis.
    Price AA; Cumberbatch M; Kimber I; Ager A
    J Exp Med; 1997 Nov; 186(10):1725-35. PubMed ID: 9362532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 1 beta and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor alpha.
    Cumberbatch M; Dearman RJ; Kimber I
    Arch Dermatol Res; 1997 Apr; 289(5):277-84. PubMed ID: 9164638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration in vivo.
    Gaiser MR; Lämmermann T; Feng X; Igyarto BZ; Kaplan DH; Tessarollo L; Germain RN; Udey MC
    Proc Natl Acad Sci U S A; 2012 Apr; 109(15):E889-97. PubMed ID: 22411813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous immune system].
    Schmitt D
    C R Seances Soc Biol Fil; 1994; 188(3):207-21. PubMed ID: 7834504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cytokines in epidermal Langerhans cell migration.
    Wang B; Amerio P; Sauder DN
    J Leukoc Biol; 1999 Jul; 66(1):33-9. PubMed ID: 10410987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells.
    Suzuki H; Wang B; Shivji GM; Toto P; Amerio P; Tomai MA; Miller RL; Sauder DN
    J Invest Dermatol; 2000 Jan; 114(1):135-41. PubMed ID: 10620129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerhans cell migration.
    Cumberbatch M; Dearman RJ; Griffiths CE; Kimber I
    Clin Exp Dermatol; 2000 Jul; 25(5):413-8. PubMed ID: 11012599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin homing of Langerhans cell precursors: adhesion, chemotaxis, and migration.
    Koch S; Kohl K; Klein E; von Bubnoff D; Bieber T
    J Allergy Clin Immunol; 2006 Jan; 117(1):163-8. PubMed ID: 16387601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockers suppress the contact hypersensitivity reaction (CHR) by inhibiting antigen transport and presentation by epidermal Langerhans cells in mice.
    Katoh N; Hirano S; Kishimoto S; Yasuno H
    Clin Exp Immunol; 1997 May; 108(2):302-8. PubMed ID: 9158102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro.
    Furue M; Katz SI
    J Immunol; 1988 Jun; 140(12):4139-43. PubMed ID: 3259608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of epidermal langerhans cells in human pathology and their potential as targets for drug development: a review of literature.
    Ayala-García I; Hernández-Segura AM; Castell-Rodríguez A; Alvarez Pérez SJ; Téllez BH; Ramírez-González MD
    Proc West Pharmacol Soc; 2005; 48():13-20. PubMed ID: 16416652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.